[
  {
    "id": 321,
    "question": "Two weeks Postpartum with headache, presented with left side weakness. MRI picture with right cortical ICH with surrounding edema",
    "option_a": "aneurysm rupture",
    "option_b": "CVT",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nPostpartum women are in a hypercoagulable state due to physiological changes of pregnancy and the postpartum period. This increases their risk for venous thromboembolic events, including cerebral venous thrombosis (CVT), which can present with headache and focal neurologic deficits.\n\n**Pathophysiology**\n\nCVT occurs when thrombi form in the cerebral venous sinuses or cortical veins. In the postpartum period, elevated coagulation factors and reduced fibrinolysis predispose to clot formation. Thrombotic occlusion leads to increased venous pressure, disruption of the blood\u2013brain barrier, vasogenic edema, and sometimes hemorrhagic venous infarction manifesting as a cortical intracerebral hemorrhage with surrounding edema.\n\n**Clinical Correlation**\n\nA postpartum woman presenting two weeks after delivery with headache and left-sided weakness fits the clinical picture for CVT. The imaging finding of a right cortical intracerebral hemorrhage with surrounding edema is consistent with a hemorrhagic venous infarction secondary to venous sinus thrombosis rather than a typical hypertensive or aneurysmal bleed.\n\n**Diagnostic Approach**\n\nThe diagnosis typically involves neuroimaging. An MRI combined with MR venography is the modality of choice to detect venous occlusions. Differential diagnoses include aneurysm rupture (which usually causes subarachnoid hemorrhage rather than a cortical hemorrhage) and primary intracerebral hemorrhage from hypertension. The patient\u2019s postpartum status and imaging findings should raise suspicion for CVT.\n\n**Management Principles**\n\nAccording to current guidelines, the mainstay of CVT treatment is early anticoagulation \u2013 typically low-molecular-weight heparin (LMWH) even when intracerebral hemorrhage is present. In the postpartum period, LMWH is preferred due to its safety profile in lactating women and its predictable pharmacokinetics. Second-line treatments might include unfractionated heparin in cases where rapid reversal might be necessary. Follow\u2010up imaging and long\u2010term anticoagulation duration are individualized based on risk factors.\n\n**Option Analysis**\n\nOption A (aneurysm rupture) is unlikely because aneurysmal subarachnoid hemorrhage typically presents with a sudden severe headache and subarachnoid blood on imaging, not a cortical ICH with surrounding edema. Marked Answer B (CVT) is correct given the patient\u2019s postpartum hypercoagulable state and the imaging findings. Options C and D were not provided.\n\n**Clinical Pearls**\n\n1. The postpartum period is a high-risk time for venous thromboembolic events, including CVT. 2. CVT can cause hemorrhagic venous infarctions, so a hemorrhage on imaging does not preclude the diagnosis. 3. Anticoagulation is indicated for CVT even in the presence of hemorrhage.\n\n**Current Evidence**\n\nRecent research and guideline updates (including AHA/ASA recommendations) emphasize early diagnosis and initiation of anticoagulation therapy in CVT. Studies have supported the safety and efficacy of LMWH in postpartum patients, reinforcing its role even when hemorrhagic infarction is present.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 322,
    "question": "75 years old female, DM, HTN who came with acute right side weakness. CTA angiography showed left ICA at 60% and right is 65% what to do",
    "option_a": "Maximize medical management",
    "option_b": "Carotid endarterectomy",
    "option_c": "Elective carotid stenting",
    "option_d": "Stenting within 1 week",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nManagement of carotid artery disease in the context of stroke is largely driven by the degree of stenosis and symptoms. Surgical interventions like carotid endarterectomy (CEA) are typically reserved for high-grade stenoses in symptomatic individuals.\n\n**Pathophysiology**\n\nAtherosclerotic plaque formation in the carotid arteries can lead to luminal narrowing. In this patient, the moderate stenosis (60-65%) suggests atherosclerotic disease that has not reached thresholds (generally \u226570% in symptomatic patients) where surgical intervention confers a significant benefit over medical therapy.\n\n**Clinical Correlation**\n\nThe elderly patient with vascular risk factors (DM and HTN) presenting with acute right-sided weakness is suggestive for an ischemic stroke. CTA findings showing moderate carotid stenosis indicate that the stroke is more likely due to small vessel or other embolic mechanisms rather than significant carotid artery obstruction warranting surgical revascularization.\n\n**Diagnostic Approach**\n\nThe diagnostic workup in stroke includes vascular imaging (like CTA or carotid Duplex ultrasound) to assess carotid stenosis. Differential diagnoses include cardioembolic stroke, intracranial atherosclerotic disease, and lacunar strokes. The decision between medical versus surgical management hinges on the degree of stenosis and whether the patient is symptomatic.\n\n**Management Principles**\n\nCurrent guidelines recommend intensive medical management (antiplatelet therapy, statins, blood pressure control, and lifestyle modifications) as the first-line approach for moderate carotid stenosis. Carotid revascularization (CEA or stenting) is indicated primarily in symptomatic patients with at least 70% stenosis. For a 75-year-old with moderate stenosis and significant comorbidities, maximizing medical therapy is most appropriate. In terms of pregnancy and lactation, this scenario does not apply; however, emphasis on medical management is similarly preferred when surgical risks outweigh benefits.\n\n**Option Analysis**\n\nOption A (Maximize medical management) is correct because the stenosis levels (60% and 65%) do not meet the threshold for surgical intervention. Option B (Carotid endarterectomy) and Option C (Elective carotid stenting) are typically reserved for higher-grade stenosis. Option D (Stenting within 1 week) is not appropriate given the degree and the acute setting without severe stenoses.\n\n**Clinical Pearls**\n\n1. In symptomatic patients, carotid revascularization is generally considered when stenosis is 70% or greater. 2. Intensive medical management is the cornerstone for moderate carotid stenosis. 3. Risk factor modification is critical in stroke prevention.\n\n**Current Evidence**\n\nRecent trials and guideline updates (including those from the AHA/ASA and the European Society for Vascular Surgery) support optimal medical therapy for moderate carotid stenosis, highlighting that surgical benefits are most pronounced in patients with high-grade (>70%) stenosis.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 323,
    "question": "Pregnant female patient with positive antiphospholipid who had a stroke was found to have small PFO, and prior history of DVT, what is the next best step",
    "option_a": "Aspirin",
    "option_b": "Close the PFO",
    "option_c": "Heparin",
    "option_d": "Warfarin",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nAntiphospholipid syndrome (APS) is an acquired thrombophilia that predisposes patients to both arterial and venous thrombosis. In pregnant patients, APS poses a significant risk for stroke and recurrent venous thromboembolic events, making anticoagulation the cornerstone of management.\n\n**Pathophysiology**\n\nAPS involves the production of antiphospholipid antibodies (eg, anticardiolipin, lupus anticoagulant) that interfere with normal coagulation. These antibodies lead to endothelial dysfunction and activation of the coagulation cascade, resulting in both arterial (stroke) and venous (DVT) thrombosis. The presence of a small patent foramen ovale (PFO) is incidental in this context and does not drive the treatment strategy.\n\n**Clinical Correlation**\n\nA pregnant woman with a history of DVT and a positive APS screen who also presents with a stroke strongly suggests that her event is due to hypercoagulability associated with APS. In pregnancy, warfarin is contraindicated owing to its teratogenicity, and PFO closure is not indicated for APS-related strokes.\n\n**Diagnostic Approach**\n\nThe diagnosis of APS is based on clinical criteria (history of thrombosis or pregnancy morbidity) plus laboratory confirmation (presence of antiphospholipid antibodies on two occasions at least 12 weeks apart). Differential considerations include cardioembolic strokes from PFO-related paradoxical embolism; however, the history of DVT and APS positivity points toward a thrombophilic process.\n\n**Management Principles**\n\nFor pregnant patients with APS, the current guideline-recommended first-line treatment is the use of heparin \u2013 typically low molecular weight heparin (LMWH) \u2013 often in combination with low-dose aspirin. This regimen is safe during pregnancy and lactation. Warfarin is contraindicated in pregnancy due to teratogenic effects, and PFO closure is not recommended given that the underlying issue is hypercoagulability rather than an anatomic shunt.\n\n**Option Analysis**\n\nOption A (Aspirin) alone is insufficient for a high-risk APS patient with a history of DVT and stroke. Option B (Close the PFO) addresses a potential embolic source but is not indicated when APS is the underlying cause. Option D (Warfarin) is contraindicated in pregnancy. Option C (Heparin) is the correct choice as it effectively anticoagulates the patient while being safe in pregnancy.\n\n**Clinical Pearls**\n\n1. In pregnant patients with APS, LMWH plus low-dose aspirin is the standard treatment to prevent recurrent thrombosis. 2. A small PFO in an APS patient is likely incidental; focus should be on managing the hypercoagulable state. 3. Warfarin is prohibited during pregnancy due to its known teratogenic risks.\n\n**Current Evidence**\n\nRecent studies and updated guidelines (including those from the American College of Rheumatology and obstetrical societies) consistently support the combined use of LMWH and aspirin in pregnant patients with APS to reduce the risk of thrombotic complications.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 324,
    "question": "Stroke within window what should be done before IV tPA.",
    "option_a": "Coagulation",
    "option_b": "Glucose Level",
    "option_c": "ECG",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nBefore administration of IV tPA for acute ischemic stroke, it is crucial to rule out mimics and contraindications. One of the rapid, bedside tests is the measurement of blood glucose, as hypoglycemia can produce stroke-like symptoms.\n\n**Pathophysiology**\n\nHypoglycemia can lead to focal neurological deficits that closely mimic a stroke. Because tPA is a potent thrombolytic agent with significant hemorrhagic risks, it is imperative to ensure that the patient\u2019s symptoms are due to true ischemic stroke rather than a metabolic disturbance.\n\n**Clinical Correlation**\n\nIn an acute stroke setting, rapid evaluation is paramount. A fingerstick blood glucose test is easily performed, and abnormal values (too low or too high) must be corrected before considering thrombolytic therapy. This helps prevent unnecessary administration of tPA to patients with stroke mimics.\n\n**Diagnostic Approach**\n\nPrior to IV tPA administration, the standard workup includes a non-contrast CT scan to exclude hemorrhage, a rapid fingerstick blood glucose measurement, and assessment of coagulation parameters if indicated (especially in patients on anticoagulants). Differential considerations include hypoglycemia, which can both mimic and worsen neurological deficits.\n\n**Management Principles**\n\nCurrent guidelines (AHA/ASA) mandate that a bedside blood glucose test be performed in all suspected stroke patients before tPA administration to rule out hypoglycemia. Although coagulation studies and ECG are also important components of the overall stroke workup, the glucose test is rapid and critical in the immediate decision-making process. In pregnancy or lactation, similar protocols are used; however, additional considerations (like radiation exposure from CT) are managed with protective measures. tPA itself is contraindicated in certain pregnancy settings but may be considered in life-threatening strokes with informed risk-benefit discussions.\n\n**Option Analysis**\n\nOption A (Coagulation) is important if there is suspicion of a coagulopathy or if the patient is on anticoagulants, but it is not as immediately critical as checking blood glucose. Option C (ECG) is useful for detecting arrhythmias (such as atrial fibrillation) that might suggest a cardioembolic source but is not a prerequisite for tPA administration. Marked Answer B (Glucose Level) is correct because verifying a normal blood glucose level is a rapid and necessary step to avoid treating a stroke mimic.\n\n**Clinical Pearls**\n\n1. Always perform a rapid fingerstick blood glucose test in suspected stroke cases before administering tPA. 2. Hypoglycemia can mimic stroke, so its prompt correction is essential. 3. Although additional tests (coagulation studies, ECG) are important, they are secondary to the immediate check of blood glucose in the acute setting.\n\n**Current Evidence**\n\nRecent AHA/ASA guidelines reiterate the necessity of checking blood glucose immediately in the acute stroke setting to ensure that the clinical picture is indeed due to ischemia and not a hypoglycemic event. This practice remains a cornerstone in the door-to-needle protocols for IV thrombolysis.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 325,
    "question": "Same picture of Moyamoya in Q12 with right side weakness and CTA showing severe stenosis in the left MCA, what to do next",
    "option_a": "Exchange Transfusion",
    "option_b": "Aspirin and Plavix",
    "option_c": "Labetalol",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nMoyamoya syndrome is characterized by progressive steno\u2010occlusive changes in the terminal portions of the internal carotid arteries and their proximal branches. In patients with sickle cell disease (SCD), a moyamoya pattern may develop as a complication of chronic vaso-occlusive injury. In the acute setting of a stroke with evidence of severe MCA stenosis in an SCD patient, rapid reduction of sickled hemoglobin (HbS) is critical.\n\n**Pathophysiology**\n\nIn SCD, abnormal hemoglobin S leads to red cell sickling under stress conditions. These sickled cells trigger endothelial injury, promoting intimal proliferation and eventual vascular stenosis and occlusion. The moyamoya\u2010like vascular changes, with the formation of fragile collateral vessels, predispose the patient to ischemic events. Urgent reduction of circulating HbS via exchange transfusion improves blood rheology and oxygen delivery, helping to limit infarct size.\n\n**Clinical Correlation**\n\nThe patient\u2019s right-sided weakness correlates with left MCA territory ischemia. In the context of a sickle cell patient showing imaging features of moyamoya, the clinical picture is that of an acute ischemic stroke precipitated by vaso-occlusion. Rapid intervention is essential to mitigate further neurologic damage.\n\n**Diagnostic Approach**\n\nDiagnosis is typically made with non-invasive imaging such as CTA or MRA to document the stenotic changes. Differential diagnoses include atherosclerotic stroke, vasculitis, or reversible cerebral vasoconstriction syndrome (RCVS), but in a young patient with SCD and moyamoya findings, vaso-occlusion is the underlying mechanism. Confirmation of sickle cell status and hemoglobin electrophoresis support the diagnosis.\n\n**Management Principles**\n\nFor an acute ischemic stroke in a sickle cell patient with moyamoya-like features, the first-line treatment is urgent exchange transfusion to reduce circulating HbS levels (aiming for <30%). This intervention is critical to arrest further sickling and ischemic injury. Long-term management may include possible revascularization surgery after stabilization and rigorous secondary stroke prevention measures. In pregnant or lactating patients with SCD, exchange transfusion is considered safe with appropriate hematologic consultation and monitoring, as the benefits in reducing ischemic brain injury outweigh potential risks.\n\n**Option Analysis**\n\nOption A (Exchange Transfusion) is correct because it directly addresses the acute pathophysiology of sickle cell\u2013related stroke by reducing HbS and improving cerebral perfusion. Option B (Aspirin and Plavix) is more appropriate for atherosclerotic or non\u2013sickle cell embolic strokes and does not address the unique pathophysiology of SCD. Option C (Labetalol) is aimed at blood pressure control and is not the primary acute treatment for sickle cell stroke.\n\n**Clinical Pearls**\n\n\u2022 In SCD patients with stroke, early exchange transfusion can limit infarct expansion.  \u2022 Moyamoya syndrome in SCD warrants careful neuroimaging evaluation.  \u2022 Time is brain \u2013 rapid intervention is essential in vaso-occlusive stroke.\n\n**Current Evidence**\n\nRecent guidelines from hematology and stroke societies support early exchange transfusion in SCD patients presenting with acute ischemic stroke. Studies have demonstrated that prompt reduction of HbS levels significantly reduces the progression of cerebral infarction, and this approach is endorsed in current SCD management protocols.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 326,
    "question": "The patient with a past medical history of stroke had a full cardiac workup but was negative. He was started on Aspirin which made his chronic epistaxis worse. Picture Attached. What to do next",
    "option_a": "Lung angiography",
    "option_b": "C-ANCA",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn patients with a history of stroke and negative cardiac sources of embolism, the occurrence of chronic epistaxis raises suspicion for an underlying systemic vascular disorder, such as Hereditary Hemorrhagic Telangiectasia (HHT). HHT is known for its mucocutaneous telangiectasias and arteriovenous malformations (AVMs), particularly in the lungs.\n\n**Pathophysiology**\n\nHHT is an autosomal dominant condition characterized by abnormal blood vessel formation. The presence of pulmonary AVMs can facilitate right-to-left shunting, bypassing the pulmonary capillary filter and predisposing individuals to paradoxical emboli, which can cause ischemic strokes. The use of aspirin may exacerbate bleeding from fragile telangiectasias, worsening epistaxis.\n\n**Clinical Correlation**\n\nThis patient\u2019s clinical profile\u2014with a past stroke, a negative cardiac workup, and chronic epistaxis worsened by aspirin\u2014strongly suggests the possibility of pulmonary AVMs secondary to HHT. Identifying a pulmonary AVM is critical since it is a correctable source of cerebral embolism.\n\n**Diagnostic Approach**\n\nAfter a negative cardiac workup, lung angiography (via CT angiography of the chest) is the imaging modality of choice to detect pulmonary AVMs. Important differentials include vasculitides (e.g., granulomatosis with polyangiitis) where C-ANCA could be positive, but the clinical constellation in HHT (recurrent nosebleeds, telangiectasias, and paradoxical embolism) is distinct.\n\n**Management Principles**\n\nThe cornerstone of management for pulmonary AVMs involves transcatheter embolization, which can reduce the risk of stroke and brain abscess. In patients with HHT, avoiding medications like aspirin that exacerbate bleeding is important. In pregnant or lactating women with HHT, careful evaluation is warranted as pulmonary AVMs may enlarge during pregnancy; embolization is generally deferred until after the first trimester and coordinated with a multidisciplinary team.\n\n**Option Analysis**\n\nOption A (Lung Angiography) is correct because it is the most direct means of detecting pulmonary AVMs that may be responsible for paradoxical embolic stroke. Option B (C-ANCA) would be used for suspected vasculitis (e.g., granulomatosis with polyangiitis) but does not align with a clinical picture dominated by epistaxis and AVM-related stroke.\n\n**Clinical Pearls**\n\n\u2022 In patients with cryptogenic stroke and recurrent epistaxis, think of HHT.  \u2022 Pulmonary AVMs facilitate paradoxical embolism and warrant prompt evaluation.  \u2022 Aspirin can exacerbate bleeding in patients with fragile telangiectasias.\n\n**Current Evidence**\n\nCurrent international consensus guidelines recommend screening for pulmonary AVMs in patients suspected of having HHT, particularly when there is a history of stroke. Emerging research emphasizes the safety and efficacy of endovascular embolization in reducing stroke risk in these patients.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 327,
    "question": "Patient with migraine headaches, father died young from a stroke. To diagnose what should you do",
    "option_a": "Skin biopsy for eosinophilic inclusions",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nCADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is an inherited small vessel disease that typically presents with migraine headaches (often with aura), cognitive decline, and a family history of premature stroke. A skin biopsy looking for granular osmiophilic material (eosinophilic inclusions) in the vessel walls is a key diagnostic test.\n\n**Pathophysiology**\n\nCADASIL is caused by mutations in the NOTCH3 gene, which leads to abnormal accumulation of the NOTCH3 extracellular domain in vascular smooth muscle cells. These deposits result in progressive degeneration of the small penetrating arteries and arterioles, leading to subcortical infarcts, white matter changes, and ultimately, stroke and cognitive impairment.\n\n**Clinical Correlation**\n\nThe presentation of migraine headaches in a patient with a family history of early stroke is highly suggestive of CADASIL. The use of a skin biopsy can reveal the characteristic eosinophilic granular deposits, helping to confirm the diagnosis.\n\n**Diagnostic Approach**\n\nWhile genetic testing for NOTCH3 mutations is increasingly used, a skin biopsy remains a reliable diagnostic tool, especially when genetic testing is unavailable or inconclusive. Differential diagnoses include other hereditary small vessel diseases; however, the combination of migraine with aura and a familial pattern strongly points toward CADASIL.\n\n**Management Principles**\n\nCurrently, there is no cure for CADASIL and management is primarily supportive, focusing on reducing stroke risk and managing symptoms (e.g., controlling blood pressure, managing migraines). Antiplatelet agents such as aspirin may be used, although their benefit in CADASIL is uncertain. In pregnant or lactating patients, treatment is symptomatic with careful selection of medications that have an acceptable safety profile during pregnancy.\n\n**Option Analysis**\n\nOption A (Skin biopsy for eosinophilic inclusions) is correct because it tests for the pathognomonic finding in CADASIL\u2014the granular osmiophilic material. Other options were not provided, but given the clinical context, skin biopsy is the appropriate diagnostic step.\n\n**Clinical Pearls**\n\n\u2022 A family history of early stroke combined with migraine with aura should raise suspicion for CADASIL.  \u2022 Skin biopsy revealing granular osmiophilic material is a hallmark of CADASIL.  \u2022 Early recognition is important for counseling and management, even though disease-specific treatment remains limited.\n\n**Current Evidence**\n\nRecent advances emphasize the role of genetic testing for NOTCH3 mutations; however, skin biopsy continues to be a valuable diagnostic adjunct. Ongoing research is investigating therapies that might modify the disease course, but current management remains supportive.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 328,
    "question": "CVT after birth what to do?",
    "option_a": "CTV",
    "option_b": "??",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nCerebral Venous Thrombosis (CVT) is a form of stroke caused by thrombosis in the cerebral venous sinuses. The postpartum period is a high-risk state for thrombosis due to a transient hypercoagulable state.\n\n**Pathophysiology**\n\nAfter childbirth, hormonal changes and a hypercoagulable state predispose patients to thrombus formation within the cerebral venous system. This can lead to impaired venous drainage, increased intracranial pressure, and venous infarction or hemorrhage.\n\n**Clinical Correlation**\n\nPatients with CVT may present with severe headache, seizures, focal neurological deficits, or signs of raised intracranial pressure. In postpartum patients, CVT should be high on the differential when these symptoms arise.\n\n**Diagnostic Approach**\n\nThe diagnostic imaging of choice for CVT is CT Venography (CTV) or MR Venography (MRV). CTV is widely available, quick, and highly sensitive in detecting venous sinus thrombosis, making it a reasonable first-line diagnostic tool. Differential diagnoses include arterial stroke, intracerebral hemorrhage, and benign postdural puncture headache, but the clinical scenario and imaging findings help clarify the diagnosis.\n\n**Management Principles**\n\nManagement of CVT generally involves prompt initiation of anticoagulation (typically with low molecular weight heparin) even in the presence of hemorrhagic infarct. In postpartum patients, anticoagulation is safe and effective, and lactation is not a contraindication. Subsequent treatment may involve transition to oral anticoagulants for a duration guided by risk factors and recurrence risk. Multidisciplinary management including neurology and hematology is important. For breastfeeding mothers, LMWH is preferred due to minimal secretion in breast milk.\n\n**Option Analysis**\n\nOption A (CTV) is correct because CT Venography is a standard, accessible, and highly accurate imaging modality for diagnosing CVT. Other options (such as MRV) may be used but were not provided here, and the given option A is appropriate for initial evaluation.\n\n**Clinical Pearls**\n\n\u2022 The postpartum period is a well-recognized risk factor for CVT.  \u2022 Early diagnosis via CT Venography can significantly improve outcomes by facilitating early anticoagulation.  \u2022 Anticoagulation is indicated even if a hemorrhagic component is present.\n\n**Current Evidence**\n\nRecent guidelines consistently support the use of CTV for rapid diagnosis of CVT. Anticoagulation (with LMWH transitioning to oral agents) remains the mainstay of treatment, and studies have validated its safety in the postpartum and lactating populations.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 329,
    "question": "Cardiac arrest in smoker patient complicated with hypotension and intubated. After 1 month came back to the clinic with chronic headaches, dizziness etc what is pathogenesis?",
    "option_a": "Hypercapnia",
    "option_b": "Vasospasm",
    "option_c": "-",
    "option_d": "",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nAfter a cardiac arrest\u2014especially in a smoker complicated by hypotension and requiring intubation\u2014the brain undergoes a period of global ischemia. The subsequent delayed neurological complaints such as chronic headaches and dizziness are most consistent with a hypoxic-ischemic injury rather than acute derangements like hypercapnia or vascular phenomena like vasospasm.\n\n**Pathophysiology**\n\nDuring cardiac arrest, cerebral blood flow ceases, leading to widespread neuronal hypoxia. Hypotension exacerbates this effect, and upon resuscitation, reperfusion injury (with production of free radicals and inflammatory mediators) may occur. This results in delayed neuronal death and white matter changes\u2014phenomena that are part of hypoxic-ischemic encephalopathy or delayed post-hypoxic leukoencephalopathy. Neither hypercapnia (which is an acute effect due to ventilation issues) nor vasospasm (more typically linked with subarachnoid hemorrhage) explains the delayed symptom picture in this patient.\n\n**Clinical Correlation**\n\nPatients recovering from cardiac arrest can develop chronic neurological deficits. In this case, persistent headache and dizziness a month later suggest that the brain suffered an ischemic insult with subsequent reperfusion injury. Such deficits are aligned with the areas of the brain that are most vulnerable to low oxygen states.\n\n**Diagnostic Approach**\n\nThe evaluation of post-cardiac arrest patients with chronic neurological symptoms usually involves brain imaging (MRI with diffusion-weighted imaging can reveal watershed or diffuse white matter changes) and sometimes EEG. Differential diagnoses include post-hypoxic encephalopathy, subtle infarcts from embolic events, or metabolic encephalopathy. Clinical context and imaging help differentiate these entities.\n\n**Management Principles**\n\nManagement is largely supportive. First-line measures include neurorehabilitation and symptomatic treatments for headaches and dizziness. There is no established pharmacological therapy to reverse hypoxic neuronal loss. In pregnant or lactating patients, conservative symptomatic management is emphasized, ensuring that agents (e.g., acetaminophen for headache) chosen are safe and that neurorehabilitative strategies are adapted appropriately.\n\n**Option Analysis**\n\nOption A (Hypercapnia) deals with acute ventilation issues and would present with acute rather than chronic symptoms. Option B (Vasospasm) is classically seen in the setting of subarachnoid hemorrhage, not following a cardiac arrest. Option C is intended to refer to the mechanism of hypoxic-ischemic injury (even though the option text was missing), which is the correct pathogenesis in this scenario.\n\n**Clinical Pearls**\n\n\u2022 Delayed neurological deficits after cardiac arrest are most commonly due to hypoxic, not hypercapnic, injury.  \u2022 Reperfusion injury is a key contributor to delayed symptomatology post-resuscitation.  \u2022 MRI with DWI is useful in detecting early hypoxic changes.\n\n**Current Evidence**\n\nRecent studies have focused on targeted temperature management during and after cardiac arrest as a means to reduce reperfusion injury. Advances in neuroimaging have enhanced early detection of hypoxic-ischemic changes, and ongoing research is evaluating neuroprotective agents for post-resuscitation care.",
    "exam_year": "2023",
    "exam_type": "Part II"
  },
  {
    "id": 330,
    "question": "Two questions of a patient has horner that does not react with cocaine or amphetamine",
    "option_a": "Post-ganglionic",
    "option_b": "Preganglionic",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nAfter a cardiac arrest\u2014especially in a smoker complicated by hypotension and requiring intubation\u2014the brain undergoes a period of global ischemia. The subsequent delayed neurological complaints such as chronic headaches and dizziness are most consistent with a hypoxic-ischemic injury rather than acute derangements like hypercapnia or vascular phenomena like vasospasm.\n\n**Pathophysiology**\n\nDuring cardiac arrest, cerebral blood flow ceases, leading to widespread neuronal hypoxia. Hypotension exacerbates this effect, and upon resuscitation, reperfusion injury (with production of free radicals and inflammatory mediators) may occur. This results in delayed neuronal death and white matter changes\u2014phenomena that are part of hypoxic-ischemic encephalopathy or delayed post-hypoxic leukoencephalopathy. Neither hypercapnia (which is an acute effect due to ventilation issues) nor vasospasm (more typically linked with subarachnoid hemorrhage) explains the delayed symptom picture in this patient.\n\n**Clinical Correlation**\n\nPatients recovering from cardiac arrest can develop chronic neurological deficits. In this case, persistent headache and dizziness a month later suggest that the brain suffered an ischemic insult with subsequent reperfusion injury. Such deficits are aligned with the areas of the brain that are most vulnerable to low oxygen states.\n\n**Diagnostic Approach**\n\nThe evaluation of post-cardiac arrest patients with chronic neurological symptoms usually involves brain imaging (MRI with diffusion-weighted imaging can reveal watershed or diffuse white matter changes) and sometimes EEG. Differential diagnoses include post-hypoxic encephalopathy, subtle infarcts from embolic events, or metabolic encephalopathy. Clinical context and imaging help differentiate these entities.\n\n**Management Principles**\n\nManagement is largely supportive. First-line measures include neurorehabilitation and symptomatic treatments for headaches and dizziness. There is no established pharmacological therapy to reverse hypoxic neuronal loss. In pregnant or lactating patients, conservative symptomatic management is emphasized, ensuring that agents (e.g., acetaminophen for headache) chosen are safe and that neurorehabilitative strategies are adapted appropriately.\n\n**Option Analysis**\n\nOption A (Hypercapnia) deals with acute ventilation issues and would present with acute rather than chronic symptoms. Option B (Vasospasm) is classically seen in the setting of subarachnoid hemorrhage, not following a cardiac arrest. Option C is intended to refer to the mechanism of hypoxic-ischemic injury (even though the option text was missing), which is the correct pathogenesis in this scenario.\n\n**Clinical Pearls**\n\n\u2022 Delayed neurological deficits after cardiac arrest are most commonly due to hypoxic, not hypercapnic, injury.  \u2022 Reperfusion injury is a key contributor to delayed symptomatology post-resuscitation.  \u2022 MRI with DWI is useful in detecting early hypoxic changes.\n\n**Current Evidence**\n\nRecent studies have focused on targeted temperature management during and after cardiac arrest as a means to reduce reperfusion injury. Advances in neuroimaging have enhanced early detection of hypoxic-ischemic changes, and ongoing research is evaluating neuroprotective agents for post-resuscitation care.",
    "exam_year": "2023",
    "exam_type": "Part II"
  }
]